[ad_1]
Mark Cuban Value Plus Drug Firm (MCCPDC) introduced it’s working with Coherus Biosciences, Inc. to promote Yusimry, a biosimilar model of the top-selling drug Humira, at a reduced value.
Yusimry is used to deal with a number of illnesses, corresponding to rheumatoid arthritis, psoriatic arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, ulcerative colitis, hidradenitis suppurativa, Crohn’s illness and plaque psoriasis.
The remedy shall be accessible by means of MCCPDC beginning July 2023, costing $569.27 plus meting out and transport charges. Will probably be the primary biologic product provided by the low cost drug provider.
In February, MCCPDC introduced a brand new program on Twitter, aiming to create an unbiased pharmacists’ community the place members can be offered a “Group Cuban Advantages Card.” MCCPDC stated in a press release that Yusimry can be included in the advantages program by means of collaborating pharmacies.
“Coherus’s Yusimry is a sport changer. Having a substitute for Humira that’s inexpensive will enhance the lives of sufferers in all places. Costplusdrugs.com is actually excited to make Yusimry accessible to everybody in a clear method,” Mark Cuban instructed MobiHealthNews in an e mail.
THE LARGER TREND
Since MCCPDC’s launch in 2022, it is developed quite a few partnerships and collaborations.
In April, the corporate introduced a collaboration with Seattle-based Zócalo Health, a digital healthcare service for Latino sufferers, to increase Zócalo members’ entry to lower-cost prescription remedy.
That very same month, Fierce Healthcare reported MCCPDC teamed up with RevSpring, a well being fee options firm, to run a program with U.S. pharmacies to make medicine extra inexpensive for customers.
MCCPDC has additionally established partnerships with California-based EmsanaRx and Tennessee-based RxPreferred Benefits and introduced collaborations with diabetes and power illness administration firm Diathrive Health and most cancers care help firm OncoPower.
MCCPDC was additionally built-in into Rightway Health‘s platform, permitting the pharmacy profit supervisor’s members entry to MCCPDC.
Final 12 months, the corporate additionally introduced its first well being plan partnership with Capital Blue Cross, noting Capital’s members may use their insurance coverage playing cards at MCCPDC immediately as of the beginning of 2023.
[ad_2]